For citations:
Fedorinov DS, Lyadov VK, Abdullayev SP, Kachanova AA, Heydarov RN, Shashkov IA, Mikhailovich VM, Surzhikov SA, Lyadova MA, Sychev IV, Galkin VN, Poddubnaya IV, Sychev DA. Pharmacogenetic markers of toxicity of FOLFOX/XELOX chemotherapy in patients with gastrointestinal tumors: a prospective observational study. Meditsinskiy sovet = Medical Council. 2023;(18):175-184. (In Russ.) https://doi.org/10.21518/ms2023-384
 
                     
         
            

































 
  Email this article
            Email this article